Sandhill Capital Partners LLC Purchases 446 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sandhill Capital Partners LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156,914 shares of the medical equipment provider’s stock after purchasing an additional 446 shares during the quarter. Intuitive Surgical comprises 4.4% of Sandhill Capital Partners LLC’s investment portfolio, making the stock its 6th biggest position. Sandhill Capital Partners LLC’s holdings in Intuitive Surgical were worth $52,937,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 0.7% in the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after purchasing an additional 196,316 shares during the last quarter. Jennison Associates LLC lifted its holdings in shares of Intuitive Surgical by 6.4% in the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock worth $1,340,205,000 after acquiring an additional 274,692 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Intuitive Surgical by 6.6% in the 3rd quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock worth $1,096,231,000 after acquiring an additional 232,205 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Intuitive Surgical by 3.4% in the 3rd quarter. Northern Trust Corp now owns 3,514,421 shares of the medical equipment provider’s stock worth $1,027,230,000 after acquiring an additional 115,059 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Intuitive Surgical by 0.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,030,415 shares of the medical equipment provider’s stock worth $593,470,000 after acquiring an additional 17,477 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.5 %

Shares of NASDAQ ISRG traded down $1.89 during mid-day trading on Thursday, reaching $373.12. The company had a trading volume of 1,262,491 shares, compared to its average volume of 1,667,548. The firm has a 50 day simple moving average of $386.40 and a two-hundred day simple moving average of $345.19. The stock has a market cap of $132.35 billion, a P/E ratio of 67.58, a PEG ratio of 4.83 and a beta of 1.36. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period last year, the firm posted $1.00 EPS. Intuitive Surgical’s revenue for the quarter was up 11.5% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 4.84 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 24,325 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the transaction, the chief executive officer now directly owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Gary S. Guthart sold 24,325 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $376.06, for a total value of $9,147,659.50. Following the completion of the sale, the chief executive officer now owns 9,425 shares in the company, valued at approximately $3,544,365.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. In the last three months, insiders have sold 255,736 shares of company stock valued at $98,639,667. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on ISRG shares. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Citigroup increased their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. BTIG Research increased their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a report on Friday, April 19th. Finally, Truist Financial increased their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $396.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.